Issue 12, 2022
From the journal:

RSC Medicinal Chemistry

Introduction to the themed collection on fragment-based drug discovery

David C. Rees,a   Anna K. H. Hirsch ORCID logo b  and  Daniel A. Erlanson ORCID logo c  

a Astex, 436 Cambridge Science Park, Cambridge CB4 0QA, UK
E-mail: David.Rees@astx.com

b Helmholtz Institute for Pharmaceutical Research Saarland – Helmholtz Centre for Infection Research and Department for Pharmacy, Saarland University, Campus E8.1, 66125 Saarbrücken, Germany
E-mail: Anna.Hirsch@helmholtz-hips.de

c Frontier Medicines, 151 Oyster Point Blvd, South San Francisco, USA
E-mail: daniel.erlanson@frontiermeds.com

Abstract

A graphical abstract is available for this content

Graphical abstract: Introduction to the themed collection on fragment-based drug discovery

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/D2MD90037H
Article type
Editorial
First published
01 Dec 2022

RSC Med. Chem., 2022,13, 1439-1439

Permissions

Request permissions

Introduction to the themed collection on fragment-based drug discovery

D. C. Rees, A. K. H. Hirsch and D. A. Erlanson, RSC Med. Chem., 2022, 13, 1439 DOI: 10.1039/D2MD90037H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements